Heidi Hagen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Heidi Hagen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Heidi Hagen. Heidi Hagen is in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Interim CEO in ZIOPHARM ONCOLOGY INC ($ZIOP).
Latest Insider Trading Transactions of Heidi Hagen
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 4.12 | 3,000 | 12,360 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 6.00 | 2,250 | 13,500 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 6.00 | 1,500 | 9,000 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 6.00 | 2,250 | 13,500 | 10,250 | 8 K to 10.3 K (+28.13 %) | |
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 4.12 | 3,000 | 12,360 | 8,000 | 5 K to 8 K (+60.00 %) | |
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 6.00 | 1,500 | 9,000 | 5,000 | 3.5 K to 5 K (+42.86 %) | |
| Mar 08 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Interim CEO | Option Exercise | A | 4.31 | 675,000 | 2,909,250 | 675,000 | |
| Mar 08 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Interim CEO | Grant | A | 0.00 | 90,000 | 0 | 122,119 | 32.1 K to 122.1 K (+280.21 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Director | Grant | A | 0.00 | 31,780 | 0 | 32,119 | 339 to 32.1 K (+9,374.63 %) |
| Jun 17 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Director | Option Exercise | A | 5.22 | 93,922 | 490,273 | 93,922 | |
| May 03 2019 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | A | 16.62 | 13,125 | 218,138 | 13,125 | ||
| May 03 2019 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | ||
| May 03 2018 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | A | 13.05 | 17,500 | 228,375 | 17,500 | ||
| May 05 2017 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | A | 2.63 | 17,500 | 46,025 | 17,500 | ||
| May 06 2016 | ASTM | Vericel Corp | Hagen Heidi | Director | Option Exercise | A | 2.76 | 15,000 | 41,400 | 15,000 | |
| Mar 24 2015 | ASTM | Vericel Corp | Hagen Heidi | Director | Option Exercise | A | 3.74 | 19,000 | 71,060 | 19,000 | |
| Jun 24 2014 | ASTM | Vericel Corp | Hagen Heidi | Director | Option Exercise | A | 4.12 | 3,000 | 12,360 | 3,000 | |
| Aug 27 2013 | ASTM | Vericel Corp | Hagen Heidi | Director | Option Exercise | A | 0.30 | 45,000 | 13,500 | 45,000 | |
| Aug 27 2013 | ASTM | Vericel Corp | Hagen Heidi | Director | Option Exercise | A | 0.30 | 30,000 | 9,000 | 30,000 |
Page: 1